|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bukowski RM: Prognostic factors for
survival in metastatic renal cell carcinoma: Update 2008. Cancer.
115(Suppl 10): S2273–S2281. 2009. View Article : Google Scholar
|
|
3
|
Sonpavde G and Choueiri TK: Biomarkers:
The next therapeutic hurdle in metastatic renal cell carcinoma. Br
J Cancer. 107:1009–1016. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Larsson SC, Kumlin M, Ingelman-Sundberg M
and Wolk A: Dietary long-chain n-3 fatty acids for the prevention
of cancer: A review of potential mechanisms. Am J Clin Nutr.
79:935–945. 2004.PubMed/NCBI
|
|
5
|
Sasazuki S, Inoue M, Iwasaki M, Sawada N,
Shimazu T, Yamaji T, Takachi R and Tsugane S: Japan Public Health
Center-Based Prospective Study Group: Intake of n-3 and n-6
polyunsaturated fatty acids and development of colorectal cancer by
subsite: Japan Public Health Center-based prospective study. Int J
Cancer. 129:1718–1729. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Terry PD, Rohan TE and Wolk A: Intakes of
fish and marine fatty acids and the risks of cancers of the breast
and prostate and of other hormone-related cancers: A review of the
epidemiologic evidence. Am J Clin Nutr. 77:532–543. 2003.PubMed/NCBI
|
|
7
|
Sonoda T, Nagata Y, Mori M, Miyanaga N,
Takashima N, Okumura K, Goto K, Naito S, Fujimoto K, Hirao Y, et
al: A case-control study of diet and prostate cancer in Japan:
Possible protective effect of traditional Japanese diet. Cancer
Sci. 95:238–242. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Spencer L, Mann C, Metcalfe M, Webb M,
Pollard C, Spencer D, Berry D, Steward W and Dennison A: The effect
of omega-3 FAs on tumour angiogenesis and their therapeutic
potential. Eur J Cancer. 45:2077–2086. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Serini S, Fasano E, Piccioni E, Monego G,
Cittadini AR, Celleno L, Ranelletti FO and Calviello G: DHA induces
apoptosis and differentiation in human melanoma cells in vitro:
Involvement of HuR-mediated COX-2 mRNA stabilization and
beta-catenin nuclear translocation. Carcinogenesis. 33:164–173.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mandal CC, Ghosh-Choudhury T, Yoneda T,
Choudhury GG and Ghosh-Choudhury N: Fish oil prevents breast cancer
cell metastasis to bone. Biochem Biophys Res Commun. 402:602–607.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang G, Panigrahy D, Mahakian LM, Yang J,
Liu JY, Lee Stephen KS, Wettersten HI, Ulu A, Hu X, Tam S, et al:
Epoxy metabolites of docosahexaenoic acid (DHA) inhibit
angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci USA.
110:6530–6535. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rogers KR, Kikawa KD, Mouradian M,
Hernandez K, McKinnon KM, Ahwah SM and Pardini RS: Docosahexaenoic
acid alters epidermal growth factor receptor-related signaling by
disrupting its lipid raft association. Carcinogenesis.
31:1523–1530. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Patterson RE, Flatt SW, Newman VA,
Natarajan L, Rock CL, Thomson CA, Caan BJ, Parker BA and Pierce JP:
Marine fatty acid intake is associated with breast cancer
prognosis. J Nutr. 141:201–206. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vaughan VC, Hassing MR and Lewandowski PA:
Marine polyunsaturated fatty acids and cancer therapy. Br J Cancer.
108:486–492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bougnoux P, Hajjaji N, Ferrasson MN,
Giraudeau B, Couet C and Le Floch O: Improving outcome of
chemotherapy of metastatic breast cancer by docosahexaenoic acid: A
phase II trial. Br J Cancer. 101:1978–1985. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lopez-Beltran A, Scarpelli M, Montironi R
and Kirkali Z: 2004 WHO classification of the renal tumors of the
adults. Eur Urol. 49:798–805. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sattler W, Puhl H, Hayn M, Kostner GM and
Esterbauer H: Determination of fatty acids in the main lipoprotein
classes by capillary gas chromatography: BF3/methanol
transesterification of lyophilized samples instead of Folch
extraction gives higher yields. Anal Biochem. 198:184–190. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gleissman H, Segerström L, Hamberg M,
Ponthan F, Lindskog M, Johnsen JI and Kogner P: Omega-3 fatty acid
supplementation delays the progression of neuroblastoma in vivo.
Int J Cancer. 128:1703–1711. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Surette ME: The science behind dietary
omega-3 fatty acids. CMAJ. 178:177–180. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zuijdgeest-van Leeuwen SD, van der Heijden
MS, Rietveld T, van den Berg JW, Tilanus HW, Burgers JA, Wilson JH
and Dagnelie PC: Fatty acid composition of plasma lipids in
patients with pancreatic, lung and oesophageal cancer in comparison
with healthy subjects. Clin Nutr. 21:225–230. 2002. View Article : Google Scholar
|
|
21
|
Cvetković Z, Vucić V, Cvetković B,
Petrović M, Ristić-Medić D, Tepsić J and Glibetić M: Abnormal fatty
acid distribution of the serum phospholipids of patients with
non-Hodgkin lymphoma. Ann Hematol. 89:775–782. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Macášek J, Vecka M, Žák A, Urbánek M,
Krechler T, Petruželka L, Staňková B and Zeman M: Plasma fatty acid
composition in patients with pancreatic cancer: Correlations to
clinical parameters. Nutr Cancer. 64:946–955. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim SP, Alt AL, Weight CJ, Costello BA,
Cheville JC, Lohse C, Allmer C and Leibovich BC: Independent
validation of the 2010 American Joint Committee on Cancer TNM
classification for renal cell carcinoma: Results from a large,
single institution cohort. J Urol. 185:2035–2039. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ebadi M and Mazurak VC: Evidence and
mechanisms of fat depletion in cancer. Nutrients. 6:5280–5297.
2014. View Article : Google Scholar : PubMed/NCBI
|
